Twitter 上的European Society of Cardiology："#MASTERDAPT trial: 1 month of #DAPT following #stent implantation in high bleeding risk patients preserves ischaemic benefits and reduces bleeding risk #ESCCongress https://t.co/DuOcldLb5Y" / Twitter
Net adverse clinical events (NACE), major adverse cardiovascular events... | Download Scientific Diagram
Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis. - Abstract - Europe PMC
Kaplan-Meier analysis of net adverse clinical events (NACE) with or... | Download Scientific Diagram
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis - Gelbenegger - 2021 - Clinical Pharmacology & Therapeutics - Wiley Online Library
HOST-REDUCE-POLYTECH-ACS
Net adverse clinical events (NACE), major adverse cardiovascular events... | Download Scientific Diagram
Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention - ScienceDirect
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy BMS & Sanofi Aventis Sponsored. - ppt download
Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty Registry | Circulation: Cardiovascular Interventions
Romagnoli E 201305
![PDF] Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3f22bb8c5b214d802d5497ec2b5b2d10138a1c95/6-Table1-1.png "PDF] Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence | Semantic Scholar")
PDF] Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence | Semantic Scholar
Effect of post‐primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta‐analysis of randomized controlled trials - Shah - 2017 - Catheterization and
Bivalirudin-Associated Major Adverse Events in ACS Patients Following PCI
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy BMS & Sanofi Aventis Sponsored. - ppt download
PLOS ONE: Unique referral system contributes to long-term net clinical benefits in patients undergoing secondary prevention therapy after percutaneous coronary intervention
GitHub - ohdsi-studies/TicagrelorVsClopidogrel: OHDSI network study: Net Adverse Clinical Event between Ticagrelor and Clopidogrel in Patients with Acute Coronary Syndrome
Impact of preprocedural coronary flow grade on duration of dual antiplatelet therapy in acute myocardial infarction | Scientific Reports
PREDICTORS OF NET ADVERSE CLINICAL EVENTS POST BALLOON AORTIC VALVULOPLASTY: RESULTS FROM THE BRAVO (EFFECT OF BIVALIRUDIN ON AORTIC VALVE INTERVENTION OUTCOMES) STUDY | Journal of the American College of Cardiology
MASTER DAPT Study
Predictors of Net Adverse Clinical Event, Major Adverse Cardiac Event,... | Download Scientific Diagram
Net Adverse Clinical Events in Patients Treated With Ticagrelor vs Clopidogrel After PCI for ACS - The Cardiology Advisor
Novedades en farmacología en intervencionismo
Preferred ACS Treatment Not Associated With Better Patient Outcomes In Contemporary Clinical Practice According To Recent Multi-National Observational Study – OHDSI
Forest plot of net adverse clinical events (NACE). | Download Scientific Diagram
